![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, February 29, 2016 10:17:35 AM
http://www.smartrelief.com
There are alternative OTC products available, suggest investigating revenues for this and similar products before contemplating theories that Big-Pharma is worried and working to limit Biel's products from wider availability.
Rational evaluation would deduce, Big-Pharma is not concerned and if they were they would have made the Biel family an "Offer they could not refuse"
Reality is this company appears to be 10-20% product based to establish 80-90% Stock selling channel. SEC has filed legal action and request the Biel family to respond to accusations with the intent of protecting further harm to investors.
Inquire with the company regarding how much funding has been derived from product sales versus how much from stock selling to unsuspecting investors? -->
Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
http://www.prnewswire.com/news-releases/bioelectronics-corporation-refutes-sec-order-for-administrative-proceedings-300216474.html
http://www.sec.gov/litigation/admin/2016/33-10036.pdf
Review the details of events that SEC feels represents multiple violations.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM